Day: 12 October 2018
Firm tackling serious disease
Par Equity and SIB back Censo’s stem cell research

Venture capital firm Par Equity and the Scottish Investment Bank (SIB) have invested £1.3m in a rapidly growing Scottish stem-cell research company helping pharmaceutical giants develop treatments for diseases includingRead More